Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q2 FY25 results · Jul–Sep 2024
Advanced Enzyme Technologies reported revenue from operations of ₹146.09 crore (down 7.4% from Q2 FY24) and net profit of ₹33.39 crore (down 5.1% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 146.09 | 157.84 | −7.4% | 154.52 | −5.5% |
| Other income | 9.62 | 6.09 | +57.8% | 6.99 | +37.5% |
| Total income | 155.71 | 163.94 | −5.0% | 161.52 | −3.6% |
| Profit before tax | 42.21 | 47.93 | −11.9% | 48.67 | −13.3% |
| Net profit for the period | 33.39 | 35.20 | −5.1% | 34.98 | −4.5% |
| Attributable to shareholders of the company | 32.83 | 34.41 | −4.6% | 34.15 | −3.9% |
| EPS, basic (₹) | 2.94 | 3.08 | −4.5% | 3.05 | −3.6% |
| Net margin (%) | 22.9 | 22.3 | 22.6 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 77.38 | 96.58 | −19.9% | 85.96 | −10.0% |
| Other income | 1.66 | 0.79 | +110.8% | 53.88 | −96.9% |
| Total income | 79.03 | 97.36 | −18.8% | 139.83 | −43.5% |
| Profit before tax | 12.32 | 24.76 | −50.2% | 72.16 | −82.9% |
| Net profit for the period | 9.13 | 18.38 | −50.3% | 67.06 | −86.4% |
| EPS, basic (₹) | 0.82 | 1.64 | −50.0% | 6.00 | −86.3% |
| Net margin (%) | 11.8 | 19.0 | 78.0 |
Consolidated
- Filed with BSE
- 09 Nov 2024, 16:23 IST
- Board meeting
- 09 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Nov 2024, 16:23 IST
- Board meeting
- 09 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE